Savara, Inc. (SVRA)
4.925
+0.10
(+1.97%)
USD |
NASDAQ |
Oct 09, 16:00
4.925
0.00 (0.00%)
After-Hours: 18:22
Savara 30-Day Average Daily Volume : 2.010M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 2.010M |
| October 07, 2026 | 1.977M |
| October 06, 2026 | 1.950M |
| October 05, 2026 | 1.918M |
| October 02, 2026 | 1.923M |
| October 01, 2026 | 1.920M |
| September 30, 2026 | 1.878M |
| September 29, 2026 | 1.727M |
| September 28, 2026 | 1.699M |
| September 25, 2026 | 1.608M |
| September 24, 2026 | 1.589M |
| September 23, 2026 | 1.545M |
| September 22, 2026 | 1.475M |
| September 21, 2026 | 1.468M |
| September 18, 2026 | 1.477M |
| September 17, 2026 | 1.438M |
| September 16, 2026 | 1.451M |
| September 15, 2026 | 1.459M |
| September 14, 2026 | 1.470M |
| September 11, 2026 | 1.465M |
| September 10, 2026 | 1.471M |
| September 09, 2026 | 1.462M |
| September 08, 2026 | 1.482M |
| September 04, 2026 | 1.553M |
| September 03, 2026 | 1.584M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.596M |
| September 01, 2026 | 1.669M |
| August 31, 2026 | 1.730M |
| August 28, 2026 | 1.710M |
| August 27, 2026 | 1.699M |
| August 26, 2026 | 1.687M |
| August 25, 2026 | 1.670M |
| August 24, 2026 | 1.679M |
| August 21, 2026 | 1.690M |
| August 20, 2026 | 1.647M |
| August 19, 2026 | 1.612M |
| August 18, 2026 | 1.638M |
| August 17, 2026 | 1.666M |
| August 14, 2026 | 1.670M |
| August 13, 2026 | 1.666M |
| August 12, 2026 | 1.654M |
| August 11, 2026 | 1.687M |
| August 10, 2026 | 1.696M |
| August 07, 2026 | 1.861M |
| August 06, 2026 | 1.896M |
| August 05, 2026 | 1.926M |
| August 04, 2026 | 1.934M |
| August 03, 2026 | 1.965M |
| July 31, 2026 | 2.069M |
| July 30, 2026 | 2.077M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Gilead Sciences, Inc. | 5.591M |
| Insmed, Inc. | 2.478M |
| United Therapeutics Corp. | 895537.1 |
| Vertex Pharmaceuticals, Inc. | 1.013M |
| ACADIA Pharmaceuticals, Inc. | 2.086M |